New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
November 13, 2017 – Allergan announced the FDA approval of Vraylar (cariprazine) for the maintenance treatment of adults with schizophrenia.
Download PDF
Return to publications
